Literature DB >> 18654087

Altered verbal working memory process in patients with Alzheimer's disease: an fMRI investigation.

Hyun-Kook Lim1, Rahyeong Juh, Chi-Un Pae, Byeong-Taek Lee, Seung-Schik Yoo, Seung-Ho Ryu, Kyeong-Rin Kwak, Chul Lee, Chang-Uk Lee.   

Abstract

Impaired working memory processing is one of the broad range of cognitive deficits in patients with Alzheimer's disease (AD). We aimed to elucidate the differences in brain activities involved in the process of working memory between AD patients and healthy comparison subjects. Twelve patients with AD were recruited along with 12 healthy volunteers as a comparison group. Functional magnetic resonance imaging was employed to assess cortical activities during the performance of a 1-back working memory paradigm using the Korean alphabet as mnemonic content. Subsequently, the difference in neural activities between the 2 groups was analyzed. The AD group performed the tasks with reduced accuracy. Group comparison analysis revealed that the AD group showed decreased brain activity in the left frontal pole (Brodmann area, BA, 10), the left ventrolateral prefrontal cortex (BA47), the left insula (BA13) and the right premotor cortex (BA6) compared to the control group. The AD group showed increased activation in the left precuneus (BA7) compared to the control group. A decreased level of activation in the prefrontal cortex and an increased level of activation in the parietal neural networks from the patient group may document an altered verbal working memory process in the patients with AD. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18654087     DOI: 10.1159/000147471

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  26 in total

1.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

Authors:  E Cavedo; S Lista; Z Khachaturian; P Aisen; P Amouyel; K Herholz; C R Jack; R Sperling; J Cummings; K Blennow; S O'Bryant; G B Frisoni; A Khachaturian; M Kivipelto; W Klunk; K Broich; S Andrieu; M Thiebaut de Schotten; J-F Mangin; A A Lammertsma; K Johnson; S Teipel; A Drzezga; A Bokde; O Colliot; H Bakardjian; H Zetterberg; B Dubois; B Vellas; L S Schneider; H Hampel
Journal:  J Prev Alzheimers Dis       Date:  2014-12

2.  Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.

Authors:  Ricardo Alvarez-Jimenez; Ellen P Hart; Samantha Prins; Marieke de Kam; Joop M A van Gerven; Adam F Cohen; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2018-02-20       Impact factor: 4.335

3.  Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.

Authors:  Anne C Baakman; Rob Zuiker; Joop M A van Gerven; Nicholas Gross; Ronghua Yang; Michael Fetell; Ari Gershon; Yossi Gilgun-Sherki; Edward Hellriegel; Ofer Spiegelstein
Journal:  Br J Clin Pharmacol       Date:  2019-03-14       Impact factor: 4.335

Review 4.  Decision-Making Competence in Patients with Alzheimer's Disease: A Review of the Literature.

Authors:  Fanny Gaubert; Hanna Chainay
Journal:  Neuropsychol Rev       Date:  2021-02-12       Impact factor: 7.444

Review 5.  Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

Authors:  Wei Qiao Qiu
Journal:  Neuroscience       Date:  2017-05-19       Impact factor: 3.590

6.  Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease.

Authors:  Jeffrey N Browndyke; Kelly Giovanello; Jeffrey Petrella; Kathleen Hayden; Ornit Chiba-Falek; Karen A Tucker; James R Burke; Kathleen A Welsh-Bohmer
Journal:  Alzheimers Dement       Date:  2012-07-28       Impact factor: 21.566

7.  Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects.

Authors:  Ricardo Alvarez-Jimenez; Geert Jan Groeneveld; Joop M A van Gerven; Sebastiaan C Goulooze; Anne Catrien Baakman; Justin L Hay; Jasper Stevens
Journal:  Br J Clin Pharmacol       Date:  2016-07-14       Impact factor: 4.335

Review 8.  Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates.

Authors:  Min Wang; Amy F T Arnsten
Journal:  Neurosci Bull       Date:  2015-03-09       Impact factor: 5.203

9.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

10.  A gene-brain-cognition pathway for the effect of an Alzheimer׳s risk gene on working memory in young adults.

Authors:  Benson W Stevens; Amanda M DiBattista; G William Rebeck; Adam E Green
Journal:  Neuropsychologia       Date:  2014-06-23       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.